What determines the specificity of TGM2's dual binding to both SDC1 and LC3 during autophagosome-lysosome fusion?

OPEN

The abstract describes TGM2 simultaneously binding SDC1 and LC3 through LIRs to coordinate autophagosome-lysosome fusion, but the molecular determinants controlling this dual interaction remain unexplained. This mechanistic gap limits understanding of how to selectively disrupt this process. Gap type: unexplained_observation Source paper: SDC1-dependent TGM2 determines radiosensitivity in glioblastoma by coordinating EPG5-mediated fusion of autophagosomes with lysosomes. (2023, Autophagy, PMID:35913916)

Priority: 0.79 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: What determines the specificity of TGM2's dual binding to both SDC1 and LC3 during autophagosome-lysosome fusion? is a 0.79 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

What determines the specificity of TGM2's dual binding to both SDC1 and LC3 during autophagosome-lysosome fusion? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (30)

LC3AutophagyLC3AUTOPHAGYINFLAMMATIONLC3LC3CANCERNEURODEGENERATIONLC3
▸ Show 25 more

associated with (5)

LC3MITOPHAGYLC3PhagocytosisLC3CancerGFPLC3LC3Tumor

encodes (1)

LC3LC3

inhibits (6)

LC3AutophagyLC3CancerLC3AlsLC3TumorAUTOPHAGYLC3
▸ Show 1 more

interacts with (5)

LC3MITOCHONDRIALC3AutophagyATGLC3LC3AlsP62LC3

regulates (2)

LC3autophagyLC3Als

therapeutic target (1)

LC3Cancer
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps